FDA Inspection 595314 — Resilience US, Inc.

Resilience US, Inc. — FEI 1000305672

The FDA completed an inspection of Resilience US, Inc. on May 28, 2009 in Allston, MA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
May 28, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Allston, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.